OCEAN BIOMEDICAL INC (OCEA) Forecast, Price Target & Analyst Ratings
NASDAQ:OCEA • US67644C1045
0.0205 USD
-0.02 (-46.75%)
At close: Apr 23, 2025
0.02 USD
0 (-2.44%)
After Hours: 4/23/2025, 8:26:33 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for OCEAN BIOMEDICAL INC (OCEA).
Forecast Snapshot
Consensus Price Target
N/A
N/A
Next Earnings Forecast
Release DateN/A
ChartMill Buy Consensus
82.86%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $0.02 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
OCEA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about OCEA.
In the previous month the buy percentage consensus was at a similar level.
OCEA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-05-31 | Taglich Brothers | Initiate | Speculative Buy |
| 2023-04-27 | EF Hutton | Maintains | Buy |
| 2023-04-13 | EF Hutton | Reiterate | Buy |
| 2023-03-16 | Fundamental Research Corp. | Initiate | Buy |
| 2023-03-13 | EF Hutton | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | |||||
| EBITDA YoY % growth | N/A | N/A | N/A -40.00% | N/A -52.48% | N/A -40.73% | |
| EBIT YoY % growth | -570K | -2.48M -335.09% | -10.214M -311.85% | -3.798M 62.82% | N/A -1,779.94% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A -422.03% | N/A 71.10% | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
OCEAN BIOMEDICAL INC / OCEA Forecast FAQ
How many analysts cover OCEAN BIOMEDICAL INC (OCEA) stock?
The number of analysts covering OCEAN BIOMEDICAL INC (OCEA) is 7.